Pompe Disease And Feeding Difficulties: Strategies For Managing Nutritional Needs
Published on: March 6, 2025
Pompe Disease And Feeding Difficulties: Strategies For Managing Nutritional Needs
  • Article reviewer photo

    Parul Vakada

    Bachelor of Science in Medicinal Chemistry

  • Article reviewer photo

    Tajwar Khatoon

    Pharmacist with a Higher Degree in Pharmaceutical Sciences from KUST, Kohat, Pakistan

Introduction

Pompe disease, a rare and complex genetic disorder, presents unique challenges when it comes to managing the nutritional needs of those affected.

The primary cause of Pompe disease in this progressive condition, also called glycogen storage disease type II, is an enzyme deficiency in acid alpha-glucosidase (GAA). GAA breaks down glycogen, a stored form of glucose, within the body's cells.1 This enzyme deficiency leads to glycogen accumulation in various tissues, particularly the muscles, heart, and liver, resulting in a range of symptoms that can profoundly influence an individual's feeding and digestion.

This article explores the nature of these feeding difficulties and provides strategies for managing dietary needs to ensure optimal health and quality of life.

As healthcare professionals and caregivers work to provide comprehensive care for those living with Pompe disease, understanding the strategies for addressing feeding difficulties and ensuring adequate nourishment is crucial. 

By implementing a multifaceted approach that caters to their individual needs, the rare condition's affected individuals can optimise their nutritional status, enhance their quality of life, and support their general well-being.

Types of pompe disease

Pompe disease is classified into two main forms: 

  • Infantile-Onset Pompe Disease (IOPD):
    • Present within the first few months of life (usually by one year)
    • Symptoms include severe muscle weakness, an enlarged liver, cardiomyopathy (enlarged heart), feeding difficulties, and respiratory insufficiency
    • Without treatment, infants with IOPD typically do not survive beyond their first two years 2
  • Late-Onset Pompe Disease (LOPD):
    • It can appear at any age (from childhood to adulthood)
    • Progression is slower, but severity varies based on the age of onset
    • Symptoms include muscle weakness (myopathy) and respiratory issues, but the heart is less affected than in IOPD

Symptoms of pompe disease

The symptoms of pompe disease vary depending on the age of onset:

Infantile-onset pompe disease

  • It typically affects infants and is the most severe form. Symptoms start within the first year of life, often around 4 months of age
  • Common signs include severe muscle weakness, an enlarged liver, and an enlarged heart (cardiomyopathy)
  • Without treatment, babies usually die of heart or respiratory failure between 1 and 2 years of age

Late-onset pompe disease

  • Symptoms can appear at any age (before 1 year without an enlarged heart)
  • Progression varies based on the age of onset
  • Features include muscle weakness (myopathy) that can lead to breathing issues

The heart is unlikely to be affected.

  • Without treatment, respiratory complications can be fatal2

Diagnosis of pompe disease

Clinical evaluation involves assessing signs and symptoms, including:

  • Poor muscle tone
  • Frequent lung infections
  • An enlarged heart

Additional tests include:

  • Enzyme Activity Tests: measure GAA enzyme activity in blood or other tissues
  • Genetic testing identifies mutations in the GAA gene3

Early detection and accurate diagnosis are crucial for timely intervention.

However, common symptoms include muscle weakness, respiratory difficulties, and, in infants, cardiomegaly (an enlarged heart). Diagnosis is usually confirmed through clinical evaluation, laboratory testing for GAA enzyme activity, and genetic testing to identify mutations in the GAA gene.

Feeding difficulties in pompe disease

Feeding difficulties in individuals with Pompe disease stem from several factors, including muscle weakness, respiratory issues, and gastrointestinal problems. These challenges can lead to inadequate nutritional intake and, consequently, malnutrition, which increases muscle weakness and other symptoms of the disease.

Muscle weakness

  • Pompe's disease affects the muscles involved in chewing and swallowing
  • Infants and young children may struggle to eat solid foods due to muscle weakness
  • Dysphagia (difficulty swallowing) increases the risk of food or liquid entering the airway, potentially causing pneumonia and respiratory complications

Respiratory issues

  • Weak respiratory muscles can hinder effective coughing, increasing the risk of aspiration
  • Coordinating breathing with eating becomes challenging for those requiring ventilatory support

Gastrointestinal problems

  • Common symptoms include gastroesophageal reflux disease (GERD), constipation, and delayed gastric emptying
  • GERD causes discomfort and aversion to eating, while constipation and delayed gastric emptying reduce appetite5

Strategies for managing nutritional needs

A multifaceted approach is often necessary to address the feeding challenges associated with Pompe disease. Healthcare professionals, in collaboration with the patient and their caregivers, must develop a comprehensive plan that takes into account the individual's specific needs, preferences, and stage of disease progression.

Dietary modifications

Adapting the diet to accommodate the individual's feeding capabilities is a crucial first step in managing nutritional needs. This may involve transitioning to a softer, more easily digestible diet, incorporating thickened liquids to reduce the risk of aspiration, or exploring specialised feeding equipment, such as feeding tubes or gastrostomy devices. Sometimes, the individual may require a feeding tube to ensure adequate caloric and nutrient intake. 6

Nutritional supplementation

When dietary changes are not enough, taking specific nutritional supplements can help make sure that a person gets all the calories and nutrients they need. These supplements could be high-protein, high-calorie formulas or enteral feeding solutions created especially for people with neuromuscular disorders like Pompe disease. The medical staff may also suggest vitamin D and mineral supplements to address deficiencies.7

Swallowing therapy and rehabilitation

Working with a speech-language pathologist or occupational therapist can be beneficial for improving swallowing function and addressing any underlying muscle weakness or coordination issues. Exercises and techniques aimed at strengthening the swallowing muscles, improving the overall swallowing process, and developing compensatory strategies can significantly improve feeding abilities and reduce the risk of aspiration.8,9

Caregiver education and support

Providing comprehensive education and support to caregivers is crucial to managing the nutritional needs of individuals with Pompe disease. Caregivers must be equipped with the knowledge and skills to effectively navigate the feeding challenges, monitor for signs of malnutrition, and collaborate with healthcare professionals to optimise the individual's nutritional status. This could involve instruction on how to use specialised feeding equipment, safe feeding practices, and methods for ensuring the right amount of calories and water are consumed.10

Multidisciplinary collaboration

 A multidisciplinary team of medical experts, including doctors, dietitians, occupational therapists, speech-language pathologists, and nurses, is frequently needed to address the nutritional needs of people with Pompe disease. The care plan is customised to the individual's particular circumstances, and their unique needs are met, thanks to this collaborative effort. 9 

Feeding techniques and equipment

Using appropriate feeding techniques and equipment can help individuals with Pompe disease consume their meals more effectively and safely. For those with severe dysphagia, feeding tubes, such as nasogastric or gastrostomy tubes, may be necessary to ensure adequate nutritional intake. These tubes can deliver nutrition directly to the stomach or intestines, bypassing the need for chewing and swallowing.11

Management of gastrointestinal symptoms

Common digestive tract symptoms associated with Pompe disease are abdominal discomfort or pain, diarrhea, constipation, bloating, vomiting, and heartburn due to gastroesophageal reflux. Below is how to manage the most common conditions.

GERD management

  • Medications: Consider proton pump inhibitors or H2 blockers to reduce discomfort associated with gastroesophageal reflux disease (GERD)
  • Dietary Modifications: Option for small, frequent meals and avoid foods that worsen reflux

Constipation relief

  • Dietary Changes: Increase fiber intake and stay hydrated
  • Laxatives: Use them if needed to improve bowel regularity

Respiratory support

For people with Pompe disease, breathing can become difficult because the muscles that help with breathing are also affected. To help with breathing, two types of respiratory support can be used:

  • Non-invasive ventilation (NIV) involves wearing a mask that helps push air into the lungs, making it easier to breathe without the need for a tube down the throat. However, the patient can’t eat during the use of NIV
  • High-flow nasal Oxygen (HFNO), delivers a steady stream of warm, humidified oxygen through tubes placed in the nostrils. Both methods can significantly improve breathing comfort and overall quality of life for people with Pompe disease, reducing the strain on weakened respiratory muscles. High-flow nasal oxygen (HFNO) may allow safer oral feeding during NIV. Coordinating nutrition and NIV:
    • Patients on NIV should receive appropriate caloric and protein intake
    • Coordinating feeding times with NIV can optimise nutritional support
    • Special NIV masks with a port for nasogastric tubes may help prevent air leakage

Speech and occupational therapy

The muscles involved in speaking and swallowing can become weaker due to Pompe disease. Speech therapy aids in managing swallowing issues and enhancing communication. Occupational therapy improves coordination and strengthens muscles to help patients carry out daily tasks. When combined, the therapies and treatments improve the lives of those who are suffering from Pompe disease.

Speech therapy

  • Muscle Strengthening: Therapists provide exercises to strengthen facial and tongue muscles, which can be weakened in Pompe disease
  • Articulation Improvement: Speech therapy helps improve speech clarity and articulation

Occupational therapy

  • Safe Swallowing Techniques: Therapists teach safe swallowing techniques to enhance eating and drinking
  • Adaptive Feeding Equipment: Recommendations for specialised utensils or cups can facilitate feeding

Case study: managing nutritional needs in infantile-onset pompe disease

An examination of a case involving a child with infantile-onset Pompe disease emphasises the significance of a thorough, customised strategy for meeting dietary requirements. The baby showed signs of acute respiratory distress, feeding issues, and muscle weakness. To create a customised treatment plan, a multidisciplinary team of a doctor, dietician, speech therapist, and respiratory therapist was brought together. The infant presented with severe muscle weakness, respiratory difficulties, and feeding problems. A multidisciplinary team, including a pediatrician, dietitian, speech therapist, and respiratory therapist, was assembled to develop a tailored care plan.14,15,16

Nutritional assessment and plan

To conduct a thorough nutritional examination, the nutritionist measured growth and took a detailed eating history. It was discovered that the baby was underweight and vulnerable to malnourishment. A high-protein, high-calorie diet was recommended, with meals pureed until readily ingested.

Feeding techniques

To conduct a thorough nutritional examination, the nutritionist measured growth and took a detailed eating history. It was discovered that the baby was underweight and vulnerable to malnourishment. A high-protein, high-calorie diet was recommended, with meals pureed until readily ingested.

Gastrointestinal management

Medication for GERD was prescribed by the pediatrician, and dietary changes were made to reduce reflux symptoms. The baby's diet tolerance was tracked by the dietitian, who suggested small, frequent feedings.

Respiratory support

The pediatrician recommended GERD medication, and dietary adjustments were made to lessen reflux symptoms. The dietician monitored the baby's nutritional tolerance and recommended frequent, modest feedings.

Outcome

The implementation of the complete treatment plan resulted in considerable improvements in the infant's growth, general health, and nutritional condition. Regular check-ups ensured that the infant's status could be monitored and the care plan could be adjusted as needed.

Summary

Patients with Pompe disease can have their nutritional needs managed using a multidisciplinary approach and tailored solutions; however, feeding issues pose major obstacles. Frequent nutritional assessments, personalised meals, suitable feeding techniques and equipment, management of gastrointestinal problems, respiratory support, and therapeutic interventions are all crucial components of care. People with Pompe disease can enhance their quality of life and health outcomes by taking care of these factors.

FAQs

What is pompe disease? 

Pompe disease is a rare genetic condition sometimes called glycogen storage disease II and acid-maltase disease. It results in the gradual weakening of the skeletal muscles and heart. Mutations in the gene that produces the enzyme acid alpha-glucosidase (GAA) cause the disease. This enzyme converts glycogen, which is a complete sugar that has been stored, into glucose, which powers our muscles. Glycogen builds up and destroys muscles when GAA deficiency is caused by mutations, especially in the heart and skeletal muscles.

What are the types of pompe disease?

Early onset (infantile form): When there is a complete or nearly total GAA deficiency, this severe type manifests itself. Early in infancy, a baby may experience feeding difficulties, poor weight gain, muscle weakness, an enlarged heart, and breathing difficulties. Most infants do not live past their first birthday if they are not treated.

Late-onset (juvenile/adult): This variant can start in childhood or maturity and is caused by partial GAA deficiency. Over several years, muscle weakness worsens and frequently results in respiratory failure. It normally does not harm the heart, unlike the infantile type.

How is pompe disease treated?

Enzyme replacement therapy (ERT) is available. Approved drugs include enzyme replacement therapy (ERT), which is available beside the proton H inhibitor, and occupational therapy.

References

  1. Kishnani, P.S., Beckemeyer, A.A., and Mendelsohn, N.J. (2012). The New Era of Pompe Disease: Advances in the Detection, Understanding of the Phenotypic Spectrum, Pathophysiology, and Management. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics, 160C, 1–7. Available from:https://onlinelibrary.wiley.com/doi/10.1002/ajmg.c.31324
  2. Stevens D., Milani-Nejad S., and Mozaffar T. Pompe disease: a clinical, diagnostic, and therapeutic overview. Curr Treat Options Neurol. 2022 Nov;24(11):573–88. Available from: https://link.springer.com/article/10.1007/s11940-022-00736-1 
  3. Gupta N, Kazi ZB, Nampoothiri S, Jagdeesh S, Kabra M, Puri RD, Muranjan M, Kalaivani M, Rehder C, Bali D, Verma IC, Kishnani PS. Clinical and molecular disease spectrum and outcomes in patients with infantile-onset Pompe disease. J Pediatr. 2020;216:44-50.e5. Available from: https://doi.org/10.1016/j.jpeds.2019.08.058.
  4. Bay LB, Denzler I, Durand C, Eiroa H, et al. Infantile-onset Pompe disease: Diagnosis and Management. Arch Argent Pediatr. 2019;117(4):271-278. Available from: http://dx.doi.org/10.5546/aap.2019.eng.271.
  5. Hirschburger M, Hecker A, Padberg W, Neubauer BA, Motz R, Haase C, Marquardt T, Hahn A. Treatment of gastroesophageal reflux with Nissen fundoplication and gastrostomy tube insertion in infantile Pompe's disease. Neuropediatrics. 2009 Feb;40(1):28-31. Available from: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0029-1231066.
  6. Iolascon G, Liguori S, Paoletta M, Moretti A. Management of musculoskeletal issues in Pompe disease. Clin Cases Miner Bone Metab. 2019 Jan 1;16(1). Available from: https://www.researchgate.net/profile/Giovanni-Iolascon/publication/335767352_Management_of_musculoskeletal_issues_in_Pompe_disease/links/5d7a3bd2a6fdcc492b5a201e/Management-of-musculoskeletal-issues-in-Pompe-disease.pdf.
  7. Swift G, Cleary M, Grunewald S, Lozano S, Ryan M, Davison J. Swallow prognosis and follow-up protocol in infantile-onset Pompe disease. In: Morava E, Baumgartner M, Patterson M, Rahman S, Zschocke J, Peters V, editors. JIMD Rep. 2016;33:11-17. Berlin, Heidelberg: Springer. Available from: https://doi.org/10.1007/8904_2016_576.
  8. Corrado B, Ciardi G, Servodio Iammarrone C. Rehabilitation management of Pompe disease, from childhood through adulthood: A systematic review of the literature. Neurol Int. 2019;11:7983. Available from: https://doi.org/10.4081/ni.2019.7983.
  9. Benedetto L, Musumeci O, Giordano A, Porcino M, Ingrassia M. Assessment of parental needs and quality of life in children with a rare neuromuscular disease (Pompe disease): a quantitative-qualitative study. Behav Sci. 2023;13(12):956. Available from: https://doi.org/10.3390/bs13120956
  10. Pietrangelo A, Jones J. Nutritionally reviewed by Jones J. May 20, 2022. Pompe disease and nutrition. Healthline [Internet]. Available from: https://www.healthline.com/health/pompe-disease-and-nutrition
  11. Korlimarla A, Lim JA, McIntosh P, Zimmerman K, Sun BD, Kishnani PS. New insights into gastrointestinal involvement in late-onset Pompe disease: lessons learned from bench and bedside. J Clin Med. 2021;10(15):3395. Available from: https://doi.org/10.3390/jcm10153395
  12. Bionews. Speech therapy. Available from: https://pompediseasenews.com/speech-therapy-pompe-disease
  13. National Institute of Neurological Disorders and Stroke. Pompe Disease. Available from: https://www.ninds.nih.gov/health-information/disorders/pompe-disease​ (NINDS)​.
  14. The Garrod Association. Guidelines and Resources. Available from: https://www.garrod.ca/guidelines-and-resources​ (The Garrod Association)​.
  15. Tarnopolsky MA, et al., Pompe Disease: Diagnosis and Management. Evidence-Based Guidelines from a Canadian Expert Panel. Can J Neurol Sci. 2023. Available from: https://www.cambridge.org/core/journals/canadian-journal-of-neurological-sciences​ (Cambridge.org)​.
Share

Hanan Fawzy Abdelmaksod Aly

Bachelor of Pharmacy, MBA in Global Management

Dr. Hanan Fawzy is a seasoned pharmaceutical plant manager with a strong background in managing and operating both sterile I.V. parenteral and non-sterile pharmaceutical products.

Holding a Bachelor of Pharmacy and an MBA in Global Management from ESLSCA Business School, Dr. Fawzy brings a wealth of expertise to the pharmaceutical industry. Passionate about medical and pharmaceutical research, Dr. Fawzy excels in translating complex scientific literature into easily understandable language for the general public.

arrow-right